Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849043 · ClinicalTrials.gov registry record
Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
A clinical trial, sponsored by Ventus Medical.
- Completed
- Registry status
- 65
- Enrollment target
NCT00849043: Completed study, sponsored by Ventus Medical.
NCT00849043 is a clinical trial that has completed, run by Ventus Medical. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00849043 has completed, sponsored by Ventus Medical.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term durability of the treatment and safety of the Provent device for those individuals who were enrolled in the C009 study, were diagnosed with obstructive sleep apnea-hypopnea (OSAH), and were actively using the Provent device.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-10 |
What the finished NCT00849043 record still lists
NCT00849043 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00849043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00849043 about?
NCT00849043 is a clinical study titled "Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea". The purpose of this study is to evaluate the long-term durability of the treatment and safety of the Provent device for those individuals who were enrolled in the C009 study, were diagnosed with obstructive sleep apnea-hypopnea (OSAH), and were actively using the Provent device.
What is the current status of trial NCT00849043?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2009-02. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00849043?
This trial is sponsored by Ventus Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia